Chiba H, Akita H, Tsuchihashi K, Hui S P, Takahashi Y, Fuda H, Suzuki H, Shibuya H, Tsuji M, Kobayashi K
Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
J Lipid Res. 1997 Jun;38(6):1204-16.
High density lipoprotein (HDL) with and without apolipoprotein (apo) E was quantified and characterized in subjects with three genotypes of cholesteryl ester transfer protein (CETP) deficiency: the nonsense mutation in intron 14 (10 homozygotes and 5 heterozygotes); the missense mutation in the exon 15 (3 homozygotes and 9 heterozygotes); and the Int14A/D442G in 6 compound heterozygotes. ApoE-poor and apoE-rich HDL-cholesterol levels were elevated significantly in all genotypic groups with the decrease in CETP activity, indicating that both types of HDL-cholesterol can be a substrate for CETP. However, an unchanged or only slightly increased serum apoA-II level in each genotype indicated that the HDL particles with apoA-II are relatively resistant to CETP-mediated lipid transfer. Serum apoE-rich HDL level was considerably higher in the Int14A homozygotes than in the compound heterozygotes, in spite of similar apoE-poor HDL-cholesterol levels, which may indicate that apoE-rich HDL is a better substrate for CETP than apoE-poor HDL. Although the apoE-rich and apoE-poor HDL subclasses were similar in the accumulation of cholesteryl ester and depletion of triglyceride, the accumulation of free cholesterol was unique to apoE-rich HDL, indicating inhibited cholesterol esterification on this lipoprotein. Clinical laboratories should be aware of the discrepancy in HDL-cholesterol measurements that comes from the different recoveries of apoE-rich HDL using commercial reagents. In conclusion, CETP deficiency causes considerable quantitative and compositional changes in HDL subclasses, reflecting a significant physiological role for CETP in HDL metabolism.
在具有三种胆固醇酯转运蛋白(CETP)缺乏基因型的受试者中,对有无载脂蛋白(apo)E的高密度脂蛋白(HDL)进行了定量和特征分析:第14内含子的无义突变(10例纯合子和5例杂合子);第15外显子的错义突变(3例纯合子和9例杂合子);以及6例复合杂合子中的Int14A/D442G。随着CETP活性降低,所有基因型组中apoE含量低和apoE含量高的HDL胆固醇水平均显著升高,表明这两种类型的HDL胆固醇都可以作为CETP的底物。然而,每种基因型中血清apoA-II水平不变或仅略有升高,表明含有apoA-II的HDL颗粒对CETP介导的脂质转移相对抗性。尽管apoE含量低的HDL胆固醇水平相似,但Int14A纯合子中的血清apoE含量高的HDL水平明显高于复合杂合子,这可能表明apoE含量高的HDL比apoE含量低的HDL更适合作为CETP的底物。尽管apoE含量高和apoE含量低的HDL亚类在胆固醇酯积累和甘油三酯消耗方面相似,但游离胆固醇的积累是apoE含量高的HDL所特有的,表明该脂蛋白上的胆固醇酯化受到抑制。临床实验室应注意使用商业试剂时,由于apoE含量高的HDL回收率不同而导致的HDL胆固醇测量差异。总之,CETP缺乏会导致HDL亚类出现相当大的数量和组成变化,反映出CETP在HDL代谢中具有重要的生理作用。